Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-30

Clinical Trial Update: Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes

View source ↗

Summary

A real-world study from Thailand assessing the effectiveness of oral semaglutide in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rybelsus (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED